Stock TRDA ENTRADA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Entrada Therapeutics, Inc.

Equities

TRDA

US29384C1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
17.15 USD -1.27% Intraday chart for Entrada Therapeutics, Inc. +21.37% +13.65%
Jun. 25 HC Wainwright Cuts Entrada Therapeutics Price Target to $18 From $20, Maintains Buy Rating MT
Jun. 24 Entrada Therapeutics Signs Securities Purchase Agreement of 3.4 Million Common Shares in Registered Direct Offering MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENTRADA THERAPEUTICS, INC. Stock Entrada Therapeutics, Inc.
 602M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 119B
ARGENX SE Stock argenx SE
 27.95B -
BIONTECH SE Stock BioNTech SE
 20.5B -
GENMAB A/S Stock Genmab A/S
 17.12B
  1. Stock Market
  2. Equities
  3. TRDA Stock
  4. Charts Entrada Therapeutics, Inc.
  5. Sector Chart